Ron Bentsur

Ron Bentsur is a Venture Advisor at Israel Biotech Fund. Previously, Ron was the CEO of UroGen Pharma (NASDAQ: URGN), former CEO of Keryx Biopharmaceuticals (NASDAQ: KERX) leading the company to the FDA approval of AuryxiaTM, former Chief Executive Officer of XTL Biopharmaceuticals.